1 / 32

Time, Dose, and Fractionation

Time, Dose, and Fractionation. Gary M. Freedman M.D. Fox Chase Cancer Center.

micheal
Download Presentation

Time, Dose, and Fractionation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Time, Dose, and Fractionation Gary M. Freedman M.D. Fox Chase Cancer Center

  2. The 4 R’s of fractionationThe radiobiological rationale behind dose fractionationThe effect of tissue type on the response to dose fractionationEffect of tissue/tumor types on / ratiosQuantitation of multi-fraction survival curvesBED and isoeffect dose calculations

  3. Repair of Sublethal Damage • Tends to improve cell survival. • Repair occurs during interval between fractions. • Needs 2 hour interval for maximal effect.

  4. Reassortment of cells within the cell cycle • Tends to reduce cell survival. • Cells move to more radiosensitive phase in the cell cycle between fractions. • M and G2 most sensitive phases. • Late S most resistant phase.

  5. Reoxygenation • Tends to reduce cell survival. • Pool of hypoxic cells diminishes after each fraction. • Oxic cells more sensitive.

  6. Repopulation • Tends to increase cell survival. • Occurs when fraction interval length greater than cell cycle doubling time.

  7. The 4 R’s of fractionationThe radiobiological rationale behind dose fractionationThe effect of tissue type on the response to dose fractionationEffect of tissue/tumor types on / ratiosQuantitation of multi-fraction survival curvesBED and isoeffect dose calculations

  8. Fractionation Sterilization Endpoint Experiments 1920’s-30’s • Single Fraction  Severe Skin Effects • Multiple Smaller Fractions  Less Severe Skin Effects

  9. Isoeffect Curves • Each isoeffect curve represents a different clinical acute toxicity endpoint. • Examples A = skin necrosis, E = skin erythema.

  10. Early Responding Tumor Skin Mucosa Intestinal Epithelium Late Responding Spinal Cord Tissue Type

  11. Mechanisms for Early vs. Late Responding Tissues • Late responders may have high percentage of resting G0 cells. • Tumors and acute tissues may cycle fast enough so that proliferation > cell kill. M G2 G1 G0 S

  12. Proliferation and Treatment Time • Normal tissues are not all the same! • Treatment time effects tumor and acute responding tissue rather than late side effects. • Accelerated repopulation occurs if treatment time too long. • For head and neck cancer, need extra 60 cGy / day after day 28 to maintain same tumor control.

  13. Tissue Type and Fractionation • Late responding tissues have larger shoulder, more curved shape of dose-response curve. Greater repair and survival at lower dose per fractions. • Early tissues have smaller shoulder, less curved shape.

  14. The 4 R’s of fractionationThe radiobiological rationale behind dose fractionationThe effect of tissue type on the response to dose fractionationEffect of tissue/tumor types on / ratiosQuantitation of multi-fraction survival curvesBED and isoeffect dose calculations

  15. / Ratios • / equal killing occurs at lower dose for late responding tissues. • Early / about 10 • Late / about 3

  16. Normal Tissue / Brenner Int J Radiat Oncol Biol Phys 60: 1013-15; 2004.

  17. The 4 R’s of fractionationThe radiobiological rationale behind dose fractionationThe effect of tissue type on the response to dose fractionationEffect of tissue/tumor types on / ratiosQuantitation of multi-fraction survival curvesBED and isoeffect dose calculations

  18. Multifraction Effects: Cell Type • Early responding tissues less sensitive to fractionation than late responding tissues. • Different cell survival curves, same fraction sizes. Late Tissue Surviving Fraction Early Tissue

  19. Hyperfractionation • Increases differences seen between acute and late effects compared with standard 2 Gy fraction size. • Reduces late effects more than acute/tumor effects (because fractionation affects late effects more).

  20. Multifraction Effects: Fraction Size • Fewer large fractions result in more severe late effects than more smaller fractions. • Same cell survival curves, different fraction sizes. Small Fraction Surviving Fraction Large Fraction

  21. Standard Regimen 70 Gy / 35 Fx / 7 wks Biologic Effective Dose = (Total Dose) x (relative effectiveness). BED = D ( 1 + d/ / ) BED3 = 70 ( 1 + 2/3 ) = 116 BED10= 70 ( 1 + 2/10 ) = 84 Proposed BID Regimen BED10= 84 = X ( 1 + 1.2/10 ) X = 75 Gy BED3 = 75 ( 1 + 1.2/3 ) = 105 Would expect less late effects But, 75 Gy / 62 Fx = 6 weeks Therefore, also shortening treatment time! Hyperfractionation studies usually increase total dose as well. Hyperfractionation

  22. 80.5 GY / 70 Fx / 7 wks 1.15 Gy BID 5 yr local control 59% Complications equal BED3 = 80.5 ( 1 + 1.15/3 ) = 111 BED10= 80.5 ( 1 + 1.15/10 ) = 90 70 Gy / 35 Fx / 7 wks 2 Gy daily 5 yr local control 40% BED3 = 70 ( 1 + 2/3 ) = 116 BED10= 70 ( 1 + 2/10 ) = 84 EORTCHead and Neck Cancer

  23. Accelerated Fractionation • Reduces treatment time to decrease effects of repopulation. • Increases acute effects. May require a break or reduced dose for patient tolerance. • No affect on late effects because total dose and fraction size the same.

  24. 72 GY / 45 Fx / 5 wks 1.6 Gy TID, 2 wk break 15% improvement in local control (expected) Complications Increased (unexpected) BED3 = 72 ( 1 + 1.6/3 ) = 110 BED10= 72 ( 1 + 1.6/10 ) = 84 70 Gy / 35 Fx / 7 wks 2 Gy daily BED3 = 70 ( 1 + 2/3 ) = 116 BED10= 70 ( 1 + 2/10 ) = 84 EORTCHead and Neck Cancer

  25. Treatment Time • Danish Head and Neck Trials • Same total dose. • Same dose per fraction. • Shorter time increased acute effects (expected). • No change in late effects (expected).

  26. RTOG 90-03 • Improved local control (expected) with hyperfractionation and accelerated fractionation without split. • Increased acute effects (expected). • No increase in late effects (expected). Fu Int J Radiat Oncol Biol Phys 48: 7 – 16; 2000.

  27. 54 GY / 36 Fx / 2 wks 1.5 Gy TID Local control the same (unexpected)*. Severe acute effects (expected). Late complications same (expected). Myelopathy increased (unexpected). BED3 = 54 ( 1 + 1.5/3 ) = 81 BED10= 54 ( 1 + 1.5/10 ) = 62* (*BED formula doesn’t account for large difference in treatment time) 70 Gy / 35 Fx / 7 wks 2 Gy daily BED3 = 70 ( 1 + 2/3 ) = 116 BED10= 70 ( 1 + 2/10 ) = 84 UKCHART

  28. Fractionation Summary • Fraction size and total dose determine late effects. • Fraction size, total dose and overall treatment time determine acute effects/tumor control. • Decreasing treatment time increases risks of acute effects, but lowers tumor repopulation. • BED calculations break down with large differences in total treatment time (tumor cell proliferation).

  29. Clinical Trial Design • Will hypofractionation of the prostate to shorten treatment time increase late effects? • Answer: Not if total dose lower. • Will it increase tumor control? • Answer: Not if prostate tumor is a slow cycler (probably not). • Answer: Depends on if it is acute or late responding tissue.

  30. The 4 R’s of fractionationThe radiobiological rationale behind dose fractionationThe effect of tissue type on the response to dose fractionationEffect of tissue/tumor types on / ratiosQuantitation of multi-fraction survival curvesBED and isoeffect dose calculations

  31. Biological Effect DoseIf / Prostate Tumor = 10 Standard Radiation: 76 Gy in 38 fractions in 2.0 Gy per fraction BED4 = 76 ( 1 + 2/4 ) Rectum = 114 BED10 = 76 ( 1 + 2/10 ) Tumor = 91 Hypofractionated Radiation: 70.2 Gy in 26 fractions in 2.7 Gy per fraction BED4 = 70.2 ( 1 + 2.7/4 ) Rectum = 118 BED10 = 70.2 ( 1 + 2.7/10 ) Tumor = 89 = X (1 + 2/10) = 74 Gy @ 2 Gy / Fx

  32. Biological Effect DoseIf / Prostate Tumor = 1.5 Standard Radiation: 76 Gy in 38 fractions in 2.0 Gy per fraction BED4 = 76 ( 1 + 2/4 ) Rectum = 114 BED1.5 = 76 ( 1 + 2/1.5 ) Tumor = 177.3 Hypofractionated Radiation: 70.2 Gy in 26 fractions in 2.7 Gy per fraction BED4 = 70.2 ( 1 + 2.7/4 ) Rectum = 118 BED1.5 = 70.2 ( 1 + 2.7/1.5 ) Tumor = 197 = X (1 + 2/1.5) = 84 Gy @ 2 Gy / Fx

More Related